Role of the extracellular signal-regulated kinase (Erk) signal transduction cascade in α2adrenoceptor-mediated vasoconstriction in porcine palmar lateral vein
- 1 July 2001
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 133 (6) , 859-866
- https://doi.org/10.1038/sj.bjp.0704149
Abstract
The mechanism of alpha(2) adrenoceptor-mediated vasoconstriction is unknown, but may involve activation of voltage-sensitive calcium channels, and/or a protein tyrosine kinase. Recently the extracellular signal-regulated kinase (Erk) cascade, often an event downstream of tyrosine kinase activation, has been shown to mediate vasoconstriction to a variety of agents. The aim of this present study was to determine the involvement of the Erk signal transduction cascade in alpha(2) adrenoceptor-mediated vasoconstriction, and to confirm the involvement of activation of voltage-sensitive calcium channels, and protein tyrosine kinase. Contractions to the alpha(2) adrenoceptor agonist UK14304 in the porcine palmar lateral vein in vitro were reduced 70 - 80% by the MEK inhibitors PD98059 (10 - 50 microM) and U0126 (10 - 50 microM), indicating the involvement of the Erk signal transduction cascade. Immunoblots also demonstrated an increase in the phosphorylated (activated) form of Erk in palmar lateral vein segments after contraction with UK14304, which was inhibited by PD98059 and U0126. The calcium channel blockers nifedipine and verapamil, or removal of extracellular calcium inhibited UK14304-induced contractions and phosphorylation of Erk, demonstrating the importance of an influx of extracellular calcium. UK14304-induced contractions were inhibited by PP2 (1 - 10 microM), a selective inhibitor of Src tyrosine kinases, but not by PP3, an inactive analogue. PP2 also prevented the phosphorylation of Erk by UK14304. These data demonstrate that alpha(2) adrenoceptor-mediated vasoconstriction in the porcine palmar lateral vein is dependent upon activation of the Erk signal transduction cascade, which is downstream of an influx of extracellular calcium, and activation of Src tyrosine kinases.Keywords
This publication has 42 references indexed in Scilit:
- Nonspecific Inhibition of Myogenic Tone by PD98059, a MEK1 Inhibitor, in Rat Middle Cerebral ArteriesBiochemical and Biophysical Research Communications, 1999
- Human vascular to cardiac tissue selectivity of L‐ and T‐type calcium channel antagonistsBritish Journal of Pharmacology, 1998
- α 2 -Adrenoceptor-mediated contractions of the porcine isolated ear artery: evidence for a cyclic AMP-dependent and a cyclic AMP-independent mechanismBritish Journal of Pharmacology, 1998
- Modulation of Voltage-dependent Ca2+Channels in Rabbit Colonic Smooth Muscle Cells by c-Src and Focal Adhesion KinasePublished by Elsevier ,1998
- Inhibition of L-type Calcium Current in Rat Ventricular Cells by the Tyrosine Kinase Inhibitor, Genistein and its Inactive Analog, DaidzeinJournal of Molecular and Cellular Cardiology, 1996
- Discovery of a Novel, Potent, and Src Family-selective Tyrosine Kinase InhibitorJournal of Biological Chemistry, 1996
- pp60c-src Increases Voltage-Operated Calcium Channel Currents in Vascular Smooth Muscle CellsBiochemical and Biophysical Research Communications, 1995
- PD 098059 Is a Specific Inhibitor of the Activation of Mitogen-activated Protein Kinase Kinase in Vitro and in VivoJournal of Biological Chemistry, 1995
- Effects of Isoflavone Compounds on the Activation of Phospholipase C.CHEMICAL & PHARMACEUTICAL BULLETIN, 1992
- UK-14,304, a potent and selective α2-agonist for the characterisation of α-adrenoceptor subtypesEuropean Journal of Pharmacology, 1981